Apadamtase alfa clinical trials
Also written TAK-755 and SHP-655.
How each study uses apadamtase alfa is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the apadamtase alfa studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
7 studies that test it; most in 2019 (2)
| Year | Studies |
|---|---|
| 2014 | 1 |
| 2017 | 1 |
| 2019 | 2 |
| 2021 | 1 |
| 2023 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 7 · Other 0
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1, 1 in phase 3
Studies that test apadamtase alfa, phase 3 first.
- Mar 2027A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic PurpuraPhase 3 · Takeda
Studies
Open first, then newest update. How each study uses apadamtase alfa is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 7
- A Study of TAK-755 in Adults With Acute Ischemic StrokeRecruitingPhase 2TakedaNCT07392450Written as TAK-755
- A Study of TAK-755 (rADAMTS13) With Little to No Plasma Exchange (PEX) Treatment in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP)CompletedPhase 2TakedaNCT05714969Written as TAK-755
- A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic PurpuraActive, not recruitingPhase 3TakedaNCT04683003Written as TAK-755
- A Study of BAX 930 in Children, Teenagers, and Adults Born With Thrombotic Thrombocytopenic Purpura (TTP)CompletedPhase 3Baxalta now part of ShireNCT03393975Written as TAK-755
- A Study of SHP655 (rADAMTS13) in Sickle Cell DiseaseCompletedPhase 1ShireNCT03997760Written as TAK-755
- Study of rADAMTS-13 (SHP655) in the Treatment of Participants With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)CompletedPhase 2ShireNCT03922308Written as SHP655
- Phase 1 Dose Escalation, Single Dose Study to Assess Safety and Pharmacokinetics of BAX930 in Hereditary Thrombotic Thrombocytopenic Purpura (TTP)CompletedPhase 1Baxalta now part of ShireNCT02216084Written as Recombinant ADAMTS13
Codes
What other systems call apadamtase alfa · ClinicalTrials.gg INT018087
- UNII (FDA) U5SFU33XUXAPADAMTASE ALFAConfirmed FDA, Wikidata
- Wikidata Q123807646apadamtase alfaConfirmed FDA, Wikidata
- NCI Thesaurus C169784Apadamtase AlfaOne source FDA
- DrugBank DB15164One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | U5SFU33XUX | APADAMTASE ALFA | Confirmed FDA, Wikidata |
| Wikidata | Q123807646 | apadamtase alfa | Confirmed FDA, Wikidata |
| NCI Thesaurus | C169784 | Apadamtase Alfa | One source FDA |
| DrugBank | DB15164 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.